Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steven Prelack currently holds 24,485 shares of GALECTIN THERAPEUTICS INC (GALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Prelack has been a net seller of GALT stock. They have purchased $0 and sold $71.0K worth of shares.
Steven Prelack's most recent insider trade was on Jun 30, 2021, when they sold 12,334 shares at $1.52 per share.
Steven Prelack serves as Executive at GALECTIN THERAPEUTICS INC (GALT). They have executed 16 insider transactions totaling $71.0K over their tenure at the company.
Steven Prelack holds the position of Executive at GALECTIN THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Steven Prelack has shown a selling trading pattern, with $0 in total purchases and $71.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Steven Prelack was on Jan 31, 2014, when they sold $243.0K worth of GALT shares. This transaction involved 17,722 shares at $13.71 per share.
Steven Prelack currently owns 24,485 shares of GALECTIN THERAPEUTICS INC (GALT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steven Prelack's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steven Prelack has 16 Form 4 filings on record as an insider at GALECTIN THERAPEUTICS INC.
Set alerts for Steven Prelack and 40,000+ other insiders.